English
Shukra Pharmaceuticals Q2 Results
- BSE: 524632
- NSE: -
- ISIN: INE551C01044
- Sector: Biotechnology & Drugs
BSE
48.20
1.58 (3.39%)
1.58 (3.39%)Volume1.86 L
Updated: Tue 13 Jan, 2026 | 12:59:26
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹5.88 Cr.(5.80%)
- Operating Profit₹-1.23 Cr.(3814.65%)
- Profit After Tax₹2.38 Cr.(341.27%)
- Operating Margin-20.91%(3600.05%)
Note: Comparison is on YoY basis
Quarterly - Shukra Pharmaceuticals Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 7.11 | 4.86 | 46.24% | 5.59 | 27.21% |
| Depreciation/ Amortization | 0.81 | 0.79 | 2.79% | 0.70 | 15.90% |
| Operating Income | -1.23 | 0.53 | 0.00% | -0.03 | 3814.65% |
| Net Income | 2.38 | 1.03 | 130.99% | 0.54 | 341.27% |
| Other Operating Expenses Total | 2.10 | 1.48 | 42.10% | 1.08 | 94.16% |
| Net Income Before Taxes | 0.20 | 1.37 | -85.55% | 0.87 | -77.32% |
| Total Revenue | 5.88 | 5.39 | 9.02% | 5.56 | 5.80% |
| Selling/ General/ Admin Expenses Total | 2.19 | 1.82 | 20.19% | 1.43 | 53.48% |
| Diluted Normalized EPS | 0.05 | 0.02 | 150.00% | 0.01 | 306.17% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.